32nd International Symposium on ALS/MND
32nd International Symposium on ALS/MND
A very delicate balance Could blocking lysosomal gatekeeper PIKfyve slow neurodegeneration?
Discovery Chemistry US
Congratulations to our 2021 Catalyst Award Winners
Verge Genomics Adds Independent Director Andrew Allen, M.D., Ph.D., to its Board of Directors
AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE WEST COAST 2021 SAN FRANCISCO
They Still Live in the Shadow of Theranos’s Elizabeth Holmes
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
Verge Genomics Presents Preclinical Data Supporting Broad-Spectrum Potential of Its Novel, Oral Antiviral at the 31st European Congress of Clinical Microbiology & Infectious Diseases
AI Transforms Genomic Data into Actionable Insights
Verge Genomics Announces the Addition of Mario Saltarelli, M.D., Ph.D., to its Scientific Advisory Board
Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer
Biotech Tilts at the Tipping Point of Gender Equality
Covid-19 Devastated Some Industries But Accelerated AI Use By Companies Across The Country
Verge Genomics Announces the Addition of Steve Kanes to its Board of Directors
Verge Genomics Announces Research Collaboration with the Sheffield Institute for Translational Neuroscience
Verge Genomics joins the Neurofilament Light Surveillance Project to Accelerate New Approaches to Diagnosing and Treating Frontotemporal Dementia
Verge Genomics Announces Publication of New Approach for Uncovering Novel Drug Targets from Human Genetics
Verge Genomics Announces the Addition of Rita Balice-Gordon, PhD, to its Scientific Advisory Board
